课题基金 / 基金详情

From pathogenesis to therapeutics: targeting two signalling pathways as a therapeutic strategy to treat preeclampsia

From pathogenesis to therapeutics: targeting two signalling pathways as a therapeutic strategy to treat preeclampsia
从发病机制到治疗:针对两个信号通路作为治疗先兆子痫的治疗策略
批准号:
nhmrc : 1126710
负责人:
Dr Natalie Hannan
金额:
$34.12万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2017
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2017-01-01 至 2019-12-31

项目摘要

项目成果

Dr Natalie Hannan的其他基金

相似基金

相关文献

中文摘要
翻译
先兆子痫是一种严重的妊娠并发症,每年夺去数千名母亲和婴儿的生命。除了分娩和胎盘外,没有有效的药物治疗。我们缺乏治疗方法很大程度上是由于我们对这种疾病的了解不足。在这个应用程序中,我们计划彻底表征我们认为负责子痫前期的两条途径,有效地确定新疗法可以靶向的许多点。
英文摘要
Preeclampsia is a serious complication of pregnancy that claims the lives of thousands of mothers and babies each year. There is no efficacious medical treatment besides delivery of the baby and placenta. Our lack of therapeutics is largely a result of our poor understanding of the disease. In this application we plan to thoroughly characterise two pathways we believe responsible for preeclampsia, effectively identifying many points at which new therapies could be targeted.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of novel therapeutics to prevent or treat preeclampsia
  • 批准号:
    nhmrc : 1146128
  • 项目类别:
    Career Development Fellowships
  • 资助金额:
    $29.14万
  • 财政年份:
    2018
  • 负责人:
    Dr Natalie Hannan
  • 依托单位:
Development of novel therapeutics to prevent or treat preeclampsia
  • 批准号:
    nhmrc : GNT1146128
  • 项目类别:
    Career Development Fellowships
  • 资助金额:
    $43.1万
  • 财政年份:
    2018
  • 负责人:
    Dr Natalie Hannan
  • 依托单位:
From pathogenesis to therapeutics: targeting two signalling pathways as a therapeutic strategy to treat preeclampsia
  • 批准号:
    nhmrc : GNT1126710
  • 项目类别:
    Project Grants
  • 资助金额:
    $49.9万
  • 财政年份:
    2017
  • 负责人:
    Dr Natalie Hannan
  • 依托单位:
New generation antiplatelet therapies to prevent preeclampsia
  • 批准号:
    nhmrc : GNT1128093
  • 项目类别:
    Project Grants
  • 资助金额:
    $48.31万
  • 财政年份:
    2017
  • 负责人:
    Dr Natalie Hannan
  • 依托单位:
国内基金
海外基金
慢病毒转染嵌合体HCN1+4拼接基因构建生物起搏细胞
  • 批准号:
    81070139
  • 项目类别:
    面上项目
  • 资助金额:
    33.0万元
  • 批准年份:
    2010
  • 负责人:
    杨向军
  • 依托单位: